Annual SGA
$11.67 M
-$7.34 M-38.61%
June 30, 2024
Summary
- As of February 8, 2025, IBIO annual SGA is $11.67 million, with the most recent change of -$7.34 million (-38.61%) on June 30, 2024.
- During the last 3 years, IBIO annual SGA has fallen by -$10.36 million (-47.01%).
- IBIO annual SGA is now -47.01% below its all-time high of $22.03 million, reached on June 30, 2021.
Performance
IBIO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.80 M
+$357.00 K+14.61%
September 30, 2024
Summary
- As of February 8, 2025, IBIO quarterly SGA is $2.80 million, with the most recent change of +$357.00 thousand (+14.61%) on September 30, 2024.
- Over the past year, IBIO quarterly SGA has increased by +$357.00 thousand (+14.61%).
- IBIO quarterly SGA is now -64.06% below its all-time high of $7.79 million, reached on December 31, 2022.
Performance
IBIO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.24 B
-$23.15 M-1.90%
September 30, 2024
Summary
- As of February 8, 2025, IBIO TTM SGA is -$1.24 billion, with the most recent change of -$23.15 million (-1.90%) on September 30, 2024.
- Over the past year, IBIO TTM SGA has dropped by -$1.25 billion (-10727.45%).
- IBIO TTM SGA is now -18205.14% below its all-time high of -$6.78 million.
Performance
IBIO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
IBIO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.6% | +14.6% | -10000.0% |
| 3 y3 years | -47.0% | -20.5% | -5425.1% |
| 5 y5 years | -5.3% | -20.5% | -5425.1% |
IBIO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -47.0% | at low | -64.1% | +14.6% | -71.3% | at low |
| 5 y | 5-year | -47.0% | +2.7% | -64.1% | +14.6% | -173.9% | at low |
| alltime | all time | -47.0% | +709.3% | -64.1% | +1024.9% | <-9999.0% | at low |
IBio Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.80 M(+14.6%) | $10.93 M(-6.4%) |
| Jun 2024 | $11.67 M(-38.6%) | $2.44 M(-10.2%) | $11.67 M(-1.4%) |
| Mar 2024 | - | $2.72 M(-8.1%) | $11.84 M(-6.4%) |
| Dec 2023 | - | $2.96 M(-16.5%) | $12.64 M(-27.7%) |
| Sep 2023 | - | $3.55 M(+36.0%) | $17.48 M(-8.1%) |
| Jun 2023 | $19.02 M(-12.6%) | $2.61 M(-26.0%) | $19.02 M(-18.4%) |
| Mar 2023 | - | $3.52 M(-54.8%) | $23.30 M(-7.1%) |
| Dec 2022 | - | $7.79 M(+53.2%) | $25.09 M(+10.7%) |
| Sep 2022 | - | $5.09 M(-26.2%) | $22.67 M(+4.2%) |
| Jun 2022 | $21.75 M(-1.3%) | $6.89 M(+29.6%) | $21.75 M(+1.1%) |
| Mar 2022 | - | $5.32 M(-1.0%) | $21.51 M(+0.0%) |
| Dec 2021 | - | $5.37 M(+28.7%) | $21.51 M(-1.3%) |
| Sep 2021 | - | $4.17 M(-37.2%) | $21.80 M(-5.2%) |
| Jun 2021 | $22.03 M(+93.8%) | $6.65 M(+25.1%) | $22.99 M(+17.8%) |
| Mar 2021 | - | $5.31 M(-6.2%) | $19.51 M(+13.6%) |
| Dec 2020 | - | $5.67 M(+5.6%) | $17.18 M(+21.9%) |
| Sep 2020 | - | $5.37 M(+69.4%) | $14.09 M(+20.3%) |
| Jun 2020 | $11.37 M(-7.8%) | $3.17 M(+6.3%) | $11.71 M(-0.5%) |
| Mar 2020 | - | $2.98 M(+15.4%) | $11.77 M(+1.2%) |
| Dec 2019 | - | $2.58 M(-13.6%) | $11.63 M(-6.5%) |
| Sep 2019 | - | $2.99 M(-7.4%) | $12.45 M(+0.9%) |
| Jun 2019 | $12.33 M(+15.4%) | $3.22 M(+13.4%) | $12.33 M(+1.9%) |
| Mar 2019 | - | $2.84 M(-16.2%) | $12.10 M(+2.0%) |
| Dec 2018 | - | $3.39 M(+18.2%) | $11.86 M(+7.3%) |
| Sep 2018 | - | $2.87 M(-4.1%) | $11.06 M(+3.5%) |
| Jun 2018 | $10.69 M(+1.3%) | $3.00 M(+15.0%) | $10.69 M(+1.0%) |
| Mar 2018 | - | $2.60 M(+0.7%) | $10.58 M(-2.1%) |
| Dec 2017 | - | $2.59 M(+3.6%) | $10.82 M(+2.2%) |
| Sep 2017 | - | $2.50 M(-13.7%) | $10.58 M(+0.3%) |
| Jun 2017 | $10.55 M(+37.3%) | $2.89 M(+2.0%) | $10.55 M(+7.3%) |
| Mar 2017 | - | $2.84 M(+20.7%) | $9.83 M(+4.6%) |
| Dec 2016 | - | $2.35 M(-4.8%) | $9.40 M(+7.6%) |
| Sep 2016 | - | $2.47 M(+13.5%) | $8.73 M(+13.6%) |
| Jun 2016 | $7.68 M | $2.18 M(-9.4%) | $7.68 M(+10.5%) |
| Mar 2016 | - | $2.40 M(+42.7%) | $6.96 M(+20.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | - | $1.68 M(+18.4%) | $5.78 M(+7.1%) |
| Sep 2015 | - | $1.42 M(-1.8%) | $5.39 M(+7.4%) |
| Jun 2015 | $5.02 M(+19.7%) | $1.45 M(+18.5%) | $5.02 M(-9.0%) |
| Mar 2015 | - | $1.22 M(-6.1%) | $5.52 M(+5.2%) |
| Dec 2014 | - | $1.30 M(+24.0%) | $5.25 M(+5.0%) |
| Sep 2014 | - | $1.05 M(-46.0%) | $5.00 M(+19.1%) |
| Jun 2014 | $4.20 M(-1.1%) | $1.95 M(+104.5%) | $4.20 M(+31.0%) |
| Mar 2014 | - | $951.00 K(-9.5%) | $3.20 M(-8.0%) |
| Dec 2013 | - | $1.05 M(+322.1%) | $3.48 M(+0.3%) |
| Sep 2013 | - | $249.00 K(-73.8%) | $3.47 M(-18.2%) |
| Jun 2013 | $4.24 M(-24.5%) | $952.00 K(-22.5%) | $4.24 M(-10.4%) |
| Mar 2013 | - | $1.23 M(+18.3%) | $4.73 M(-0.4%) |
| Dec 2012 | - | $1.04 M(+1.6%) | $4.75 M(-12.9%) |
| Sep 2012 | - | $1.02 M(-29.1%) | $5.46 M(-2.9%) |
| Jun 2012 | $5.62 M(-20.7%) | $1.44 M(+15.8%) | $5.62 M(-18.3%) |
| Mar 2012 | - | $1.25 M(-28.6%) | $6.88 M(-9.0%) |
| Dec 2011 | - | $1.75 M(+46.8%) | $7.57 M(+7.1%) |
| Sep 2011 | - | $1.19 M(-56.0%) | $7.07 M(-0.3%) |
| Jun 2011 | $7.09 M(+242.1%) | $2.70 M(+40.3%) | $7.09 M(+43.3%) |
| Mar 2011 | - | $1.93 M(+54.7%) | $4.95 M(+39.0%) |
| Dec 2010 | - | $1.25 M(+2.7%) | $3.56 M(+26.4%) |
| Sep 2010 | - | $1.21 M(+115.5%) | $2.82 M(+36.0%) |
| Jun 2010 | $2.07 M(+14.8%) | $562.90 K(+4.8%) | $2.07 M(+1.7%) |
| Mar 2010 | - | $537.30 K(+6.9%) | $2.04 M(+6.9%) |
| Dec 2009 | - | $502.80 K(+7.4%) | $1.90 M(+3.6%) |
| Sep 2009 | - | $468.20 K(-11.3%) | $1.84 M(-1.6%) |
| Jun 2009 | $1.80 M(-0.7%) | $527.70 K(+30.3%) | $1.87 M(-13.9%) |
| Mar 2009 | - | $405.10 K(-7.2%) | $2.17 M(+0.8%) |
| Dec 2008 | - | $436.50 K(-12.2%) | $2.15 M(-2.0%) |
| Sep 2008 | - | $497.40 K(-40.1%) | $2.20 M(-0.0%) |
| Jun 2008 | $1.82 M(+26.0%) | $829.90 K(+113.5%) | $2.20 M(+60.7%) |
| Mar 2008 | - | $388.70 K(-19.0%) | $1.37 M(+39.7%) |
| Dec 2007 | - | $480.10 K(-3.6%) | $978.10 K(+96.4%) |
| Sep 2007 | - | $498.00 K | $498.00 K |
| Jun 2007 | $1.44 M | - | - |
FAQ
- What is iBio annual SGA?
- What is the all time high annual SGA for iBio?
- What is iBio annual SGA year-on-year change?
- What is iBio quarterly SGA?
- What is the all time high quarterly SGA for iBio?
- What is iBio quarterly SGA year-on-year change?
- What is iBio TTM SGA?
- What is the all time high TTM SGA for iBio?
- What is iBio TTM SGA year-on-year change?
What is iBio annual SGA?
The current annual SGA of IBIO is $11.67 M
What is the all time high annual SGA for iBio?
iBio all-time high annual SGA is $22.03 M
What is iBio annual SGA year-on-year change?
Over the past year, IBIO annual SGA has changed by -$7.34 M (-38.61%)
What is iBio quarterly SGA?
The current quarterly SGA of IBIO is $2.80 M
What is the all time high quarterly SGA for iBio?
iBio all-time high quarterly SGA is $7.79 M
What is iBio quarterly SGA year-on-year change?
Over the past year, IBIO quarterly SGA has changed by +$357.00 K (+14.61%)
What is iBio TTM SGA?
The current TTM SGA of IBIO is -$1.24 B
What is the all time high TTM SGA for iBio?
iBio all-time high TTM SGA is -$6.78 M
What is iBio TTM SGA year-on-year change?
Over the past year, IBIO TTM SGA has changed by -$1.25 B (-10727.45%)